HELT
gene geneOn this page
Also known as HESLHCM1228MgnbHLHb44MEGANE
Summary
HELT (helt bHLH transcription factor, HGNC:33783) is a protein-coding gene on chromosome 4q35.1, encoding Hairy and enhancer of split-related protein HELT (A6NFD8). Transcriptional repressor which binds preferentially to the canonical E box sequence 5’-CACGCG-3'.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of neurogenesis. Predicted to act upstream of or within several processes, including nervous system development; regulation of transcription by RNA polymerase II; and suckling behavior. Predicted to be located in chromatin. Predicted to be part of transcription regulator complex. Predicted to be active in nucleus.
Source: NCBI Gene 391723 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 70 total
- MANE Select transcript:
NM_001300781
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33783 |
| Approved symbol | HELT |
| Name | helt bHLH transcription factor |
| Location | 4q35.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HESL, HCM1228, Mgn, bHLHb44, MEGANE |
| Ensembl gene | ENSG00000187821 |
| Ensembl biotype | protein_coding |
| OMIM | 617546 |
| Entrez | 391723 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron
ENST00000338875, ENST00000505610, ENST00000513599, ENST00000515777
RefSeq mRNA: 2 — MANE Select: NM_001300781
NM_001300781, NM_001300782
CCDS: CCDS75214, CCDS75215
Canonical transcript exons
ENST00000515777 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001384651 | 185019387 | 185019491 |
| ENSE00002050326 | 185019747 | 185019843 |
| ENSE00003928994 | 185020273 | 185020953 |
| ENSE00003932612 | 185018490 | 185018955 |
Expression profiles
Bgee: expression breadth broad, 24 present calls, max score 60.28.
Top tissues by expression
120 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of leg | UBERON:0001511 | 60.28 | gold quality |
| zone of skin | UBERON:0000014 | 59.08 | gold quality |
| skin of abdomen | UBERON:0001416 | 58.11 | gold quality |
| right lung | UBERON:0002167 | 56.73 | gold quality |
| metanephros cortex | UBERON:0010533 | 54.41 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 52.81 | gold quality |
| kidney | UBERON:0002113 | 48.33 | gold quality |
| sural nerve | UBERON:0015488 | 44.10 | gold quality |
| cortex of kidney | UBERON:0001225 | 43.94 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 43.29 | gold quality |
| lung | UBERON:0002048 | 40.32 | gold quality |
| spleen | UBERON:0002106 | 39.74 | gold quality |
| bone marrow cell | CL:0002092 | 38.23 | gold quality |
| ganglionic eminence | UBERON:0004023 | 38.18 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| body of stomach | UBERON:0001161 | 36.89 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| stomach | UBERON:0000945 | 35.78 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.85 | gold quality |
| fundus of stomach | UBERON:0001160 | 34.38 | gold quality |
| bone marrow | UBERON:0002371 | 32.80 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 32.14 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.88 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.67 | gold quality |
| monocyte | CL:0000576 | 28.24 | gold quality |
| leukocyte | CL:0000738 | 28.18 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.20 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| HELT |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2628.1 | HELT | Hairy-related factors |
JASPAR matrix evidence (PMIDs): PMID:14764602
Upstream regulators (CollecTRI, top): DACH2, FOXA1, FOXA2, HELT
Literature-anchored findings (GeneRIF, showing 2)
- identified and characterized human HES-like (HESL), rat hesl, and rainbow trout hesl genes by using bioinformatics (PMID:15375612)
- Activation of DPF3a upon hypertrophic stimuli in cardiac hypertrophy switches cardiac fetal gene expression from being silenced by HEY to being activated by BRG1. (PMID:26582913)
Cross-species orthologs
12 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | helt | ENSDARG00000056400 |
| mus_musculus | Helt | ENSMUSG00000047171 |
| rattus_norvegicus | Helt | ENSRNOG00000010785 |
| drosophila_melanogaster | E(spl)m8-HLH | FBGN0000591 |
| drosophila_melanogaster | E(spl)m3-HLH | FBGN0002609 |
| drosophila_melanogaster | E(spl)m5-HLH | FBGN0002631 |
| drosophila_melanogaster | E(spl)m7-HLH | FBGN0002633 |
| drosophila_melanogaster | E(spl)mbeta-HLH | FBGN0002733 |
| drosophila_melanogaster | E(spl)mdelta-HLH | FBGN0002734 |
| drosophila_melanogaster | E(spl)mgamma-HLH | FBGN0002735 |
| drosophila_melanogaster | Hesr | FBGN0030899 |
| drosophila_melanogaster | cwo | FBGN0259938 |
Paralogs (12): HES2 (ENSG00000069812), HES1 (ENSG00000114315), BHLHE41 (ENSG00000123095), BHLHE40 (ENSG00000134107), HEY2 (ENSG00000135547), HES6 (ENSG00000144485), HEYL (ENSG00000163909), HEY1 (ENSG00000164683), HES3 (ENSG00000173673), HES7 (ENSG00000179111), HES4 (ENSG00000188290), HES5 (ENSG00000197921)
Protein
Protein identifiers
Hairy and enhancer of split-related protein HELT — A6NFD8 (reviewed: A6NFD8)
Alternative names: HES/HEY-like transcription factor
All UniProt accessions (2): A0A087WSW0, A6NFD8
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional repressor which binds preferentially to the canonical E box sequence 5’-CACGCG-3'.
Subunit / interactions. Self-associates. Interacts with HES5 and HEY2.
Subcellular location. Nucleus.
Similarity. Belongs to the HEY family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A6NFD8-3 | 1 | yes |
| A6NFD8-4 | 2 |
RefSeq proteins (2): NP_001287710, NP_001287711 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003650 | Orange_dom | Domain |
| IPR011598 | bHLH_dom | Domain |
| IPR036638 | HLH_DNA-bd_sf | Homologous_superfamily |
| IPR050370 | HES_HEY | Family |
Pfam: PF00010, PF07527
UniProt features (6 total): domain 2, chain 1, modified residue 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NFD8-F1 | 66.94 | 0.31 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 48
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 44 (showing top):
GOBP_BEHAVIOR, GOBP_SUCKLING_BEHAVIOR, GOBP_GROWTH, GOBP_NEUROGENESIS, GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, GOBP_GABAERGIC_NEURON_DIFFERENTIATION, GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION, GROSS_ELK3_TARGETS_DN, GROSS_HIF1A_TARGETS_DN, GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP, GOBP_MULTICELLULAR_ORGANISM_GROWTH, chr4q35, GOBP_REGULATION_OF_CELL_DEVELOPMENT, GOBP_POST_EMBRYONIC_DEVELOPMENT, KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3
GO Biological Process (14): suckling behavior (GO:0001967), regulation of transcription by RNA polymerase II (GO:0006357), transcription by RNA polymerase II (GO:0006366), central nervous system development (GO:0007417), post-embryonic development (GO:0009791), anterior/posterior pattern specification (GO:0009952), GABAergic neuron differentiation in basal ganglia (GO:0021858), multicellular organism growth (GO:0035264), positive regulation of transcription by RNA polymerase II (GO:0045944), regulation of neurogenesis (GO:0050767), negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of DNA-templated transcription (GO:0006355), gene expression (GO:0010467), GABAergic neuron differentiation (GO:0097154)
GO Molecular Function (8): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), identical protein binding (GO:0042802), protein dimerization activity (GO:0046983), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515)
GO Cellular Component (3): chromatin (GO:0000785), nucleus (GO:0005634), transcription regulator complex (GO:0005667)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 3 |
| regulation of transcription by RNA polymerase II | 3 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| regulation of DNA-templated transcription | 2 |
| DNA-templated transcription | 2 |
| multicellular organismal process | 2 |
| protein binding | 2 |
| feeding behavior | 1 |
| nervous system development | 1 |
| system development | 1 |
| multicellular organism development | 1 |
| regionalization | 1 |
| GABAergic neuron differentiation | 1 |
| developmental growth | 1 |
| positive regulation of DNA-templated transcription | 1 |
| neurogenesis | 1 |
| regulation of nervous system development | 1 |
| regulation of cell development | 1 |
| negative regulation of DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| macromolecule biosynthetic process | 1 |
| neuron differentiation | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
478 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HELT | SLC6A7 | Q99884 | 801 |
| HELT | ASCL1 | P50553 | 624 |
| HELT | TAL2 | Q16559 | 504 |
| HELT | WDR83OS | Q9Y284 | 473 |
| HELT | ING2 | Q9H160 | 427 |
| HELT | HES3 | Q5TGS1 | 396 |
| HELT | SNX25 | Q9H3E2 | 391 |
| HELT | SLC25A4 | P12235 | 371 |
| HELT | SOX14 | O95416 | 354 |
| HELT | OVOL1 | O14753 | 353 |
| HELT | GATM | P50440 | 353 |
| HELT | SORBS2 | O94875 | 344 |
| HELT | MLX | Q9UH92 | 342 |
| HELT | PDLIM3 | Q53GG5 | 328 |
| HELT | MNT | Q99583 | 321 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HELT | SORT1 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (12): HELT (Two-hybrid), HELT (Two-hybrid), HELT (Two-hybrid), HELT (Two-hybrid), HELT (Two-hybrid), HELT (Two-hybrid), HELT (Two-hybrid), MAGEA12 (Two-hybrid), GPSM3 (Two-hybrid), HELT (Affinity Capture-MS), SORT1 (Affinity Capture-MS), HELT (Affinity Capture-MS)
ESM2 similar proteins: A4D2P6, A5PJV8, A6NFD8, D4AE48, O00268, O00287, O35274, O35779, O43566, P04198, P12755, P55199, Q08DA0, Q0D2I5, Q2KJ58, Q504T8, Q5XKK7, Q60698, Q61976, Q6NZ67, Q6P582, Q6R891, Q6T4P5, Q7Z6J2, Q80YR4, Q86UD0, Q86UK7, Q8BXL9, Q8CEG5, Q8R4T5, Q8TF61, Q8VCG9, Q969F2, Q969G9, Q96HZ4, Q96SB3, Q99PV5, Q9BQ61, Q9BUN5, Q9BZE9
Diamond homologs: A0MLS5, A6NFD8, O00327, O02219, O02748, O08785, O15516, O15945, O61734, O88529, P27540, P41739, P53762, P79832, P90953, P97460, Q2NL18, Q2VPD4, Q5R4T2, Q5RAK8, Q5ZQU2, Q61324, Q6YGZ4, Q6YGZ5, Q78E60, Q7TS99, Q8BGD7, Q8IUM7, Q8QGQ6, Q8QGQ7, Q8WYA1, Q91YA8, Q91YA9, Q91YB0, Q91YB2, Q99743, Q9BE97, Q9DBX7, Q9DG12, Q9EPW1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
70 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
433 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:185018951:GCAAA:G | donor_gain | 1.0000 |
| 4:185018956:G:GG | donor_gain | 1.0000 |
| 4:185019045:G:GT | donor_gain | 1.0000 |
| 4:185019386:GA:G | acceptor_gain | 1.0000 |
| 4:185019386:GAGA:G | acceptor_gain | 1.0000 |
| 4:185019832:G:T | donor_gain | 1.0000 |
| 4:185020271:A:AG | acceptor_gain | 1.0000 |
| 4:185020272:G:GT | acceptor_gain | 1.0000 |
| 4:185020272:GC:G | acceptor_gain | 1.0000 |
| 4:185020272:GCA:G | acceptor_gain | 1.0000 |
| 4:185020272:GCAGA:G | acceptor_gain | 1.0000 |
| 4:185018948:A:T | donor_gain | 0.9900 |
| 4:185018952:CAAAG:C | donor_loss | 0.9900 |
| 4:185018953:AAAG:A | donor_loss | 0.9900 |
| 4:185018954:AA:A | donor_gain | 0.9900 |
| 4:185018954:AAGTG:A | donor_loss | 0.9900 |
| 4:185018955:AG:A | donor_loss | 0.9900 |
| 4:185018956:G:C | donor_loss | 0.9900 |
| 4:185018957:TGA:T | donor_loss | 0.9900 |
| 4:185018958:GAG:G | donor_loss | 0.9900 |
| 4:185018994:G:GA | donor_gain | 0.9900 |
| 4:185019060:GACTT:G | donor_gain | 0.9900 |
| 4:185019381:TCGCA:T | acceptor_loss | 0.9900 |
| 4:185019382:CGCA:C | acceptor_loss | 0.9900 |
| 4:185019384:CA:C | acceptor_loss | 0.9900 |
| 4:185019385:A:AG | acceptor_gain | 0.9900 |
| 4:185019385:A:G | acceptor_loss | 0.9900 |
| 4:185019386:G:GG | acceptor_gain | 0.9900 |
| 4:185019386:G:GT | acceptor_loss | 0.9900 |
| 4:185019386:GAGAA:G | acceptor_gain | 0.9900 |
AlphaMissense
1570 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:185019414:G:A | E19K | 1.000 |
| 4:185019415:A:T | E19V | 1.000 |
| 4:185019416:A:C | E19D | 1.000 |
| 4:185019416:A:T | E19D | 1.000 |
| 4:185019417:A:G | K20E | 1.000 |
| 4:185019419:G:C | K20N | 1.000 |
| 4:185019419:G:T | K20N | 1.000 |
| 4:185019421:G:C | R21P | 1.000 |
| 4:185019423:A:G | R22G | 1.000 |
| 4:185019423:A:T | R22W | 1.000 |
| 4:185019424:G:C | R22T | 1.000 |
| 4:185019424:G:T | R22M | 1.000 |
| 4:185019425:G:C | R22S | 1.000 |
| 4:185019425:G:T | R22S | 1.000 |
| 4:185019426:A:T | R23W | 1.000 |
| 4:185019427:G:C | R23T | 1.000 |
| 4:185019427:G:T | R23M | 1.000 |
| 4:185019428:G:C | R23S | 1.000 |
| 4:185019428:G:T | R23S | 1.000 |
| 4:185019433:G:T | R25M | 1.000 |
| 4:185019434:G:C | R25S | 1.000 |
| 4:185019434:G:T | R25S | 1.000 |
| 4:185019436:T:A | I26N | 1.000 |
| 4:185019436:T:C | I26T | 1.000 |
| 4:185019436:T:G | I26S | 1.000 |
| 4:185019438:A:G | N27D | 1.000 |
| 4:185019440:C:A | N27K | 1.000 |
| 4:185019440:C:G | N27K | 1.000 |
| 4:185019444:T:C | C29R | 1.000 |
| 4:185019448:T:C | L30S | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000423070 (4:185017863 A>C), RS1002412120 (4:185018225 A>C), RS1002729140 (4:185018198 C>T), RS1002784837 (4:185018466 C>A,T), RS1003515852 (4:185021174 G>A), RS1003610902 (4:185021352 G>C), RS1004191025 (4:185019639 G>A,T), RS1004467678 (4:185019882 G>A,C,T), RS1004668764 (4:185017022 G>A), RS1005506590 (4:185020244 C>G), RS1006140277 (4:185018483 G>T), RS1007042533 (4:185021431 A>C), RS1007479824 (4:185019290 C>T), RS1008478037 (4:185017838 C>G,T), RS1008805170 (4:185017336 A>G)
Disease associations
OMIM: gene MIM:617546 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003542_35 | Night sleep phenotypes | 6.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium | increases abundance, increases expression, decreases expression | 2 |
| bisphenol A | affects cotreatment, increases methylation | 1 |
| arsenite | increases methylation | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.